Ham-sur-Heure, Belgium

Emile Cavoy


 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2000-2009

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Emile Cavoy: Innovator in Pharmaceutical Chemistry

Introduction

Emile Cavoy is a notable inventor based in Ham-sur-Heure, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work primarily focuses on the development of innovative compounds and processes that enhance the manufacturing of important pharmaceutical products.

Latest Patents

Cavoy's latest patents include advancements in oxopyrrolidine compounds, specifically the preparation of (S)-(−)-α-ethyl-2-oxo-1-pyrrolidine acetamide and its analogues. This invention presents an improved process for synthesizing these compounds, which are crucial in the production of Levetiracetam and its analogues. Additionally, he has developed new enantiomerically pure piperazine derivatives, which serve as synthesis intermediates for pharmaceutically active compounds.

Career Highlights

Throughout his career, Emile Cavoy has worked with prominent companies in the pharmaceutical industry, including UCB S.A. and Daicel Chemical Industries, Ltd. His expertise in chemical synthesis and compound development has positioned him as a valuable asset in these organizations.

Collaborations

Cavoy has collaborated with notable colleagues such as Michel Hamende and Vincent Zimmermann. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Emile Cavoy's innovative work in pharmaceutical chemistry has led to significant advancements in the field. His contributions through various patents demonstrate his commitment to improving drug manufacturing processes and developing new compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…